2
0

Moderna And Other Vaccine Maker Stocks Tumble After Trump Taps RFK Jr. As HHS Head


 invite response                
2024 Nov 14, 3:46pm   186 views  9 comments

by Al_Sharpton_for_President   ➕follow (5)   💰tip   ignore  

Stocks linked to vaccine developers such as Moderna, Pfizer and Novavax tanked in the leadup to market close Thursday, tumbling after reports surfaced that President-elect Donald Trump would select vaccine skeptic Robert F. Kennedy Jr. as the head of the Department of Health and Human Services.

Key Facts

Trump confirmed his selection of RFK Jr. on Thursday afternoon, making the announcement via Truth Social that the former independent presidential candidate would be nominated as the secretary of the Department of Health and Human Services.

Novavax and BioNTech closed down more than 7%, with almost all of the losses coming after news broke of the selection—Novavax shares dropped to $7.22 as BioNTech shares slid to $103.56.

Moderna’s stock closed down 5.6% at $39.77, bringing the stock to its lowest point of the year.

Sanofi’s stock dropped 3.4% to $47.82, continuing a weeks-long drop in share price triggered after its latest earnings report last month.

Pfizer experienced minor losses compared to its competitors Thursday and closed down 2.6% at $26.02, though it also had its sharpest drop of the day immediately after the RFK Jr. news.

Pfizer, Sanofi, BioNTech and Moderna shares have dropped since the start of the year. However, Moderna’s stock has tumbled far further than its peers, dropping more than 60% since January, when it traded at $112.50 per share. The biotech company’s stock peaked at $166 this summer and began trading below the $40 mark Thursday.

RFK Jr. has built a reputation as a vaccine skeptic but has stopped short of adopting the “anti-vaxx” label attributed to him by critics. The former environmental lawyer has said his children are vaccinated and that he does not oppose safe vaccines. RFK Jr., who repeatedly promoted the debunked theory that vaccines cause autism, has also falsely claimed COVID-19 targets “Caucasians and Black people” and that Ashkenazi Jews and Chinese people are most immune to the illness. He said last month while running for president he was “not going to take anyone's vaccines away from them,” noting he wants Americans to know “the safety profile, the risk profile, and the efficacy of each vaccine.” Kennedy has also vowed to remove fluoride from public water and “get toxins out of our food.”

https://www.msn.com/en-us/health/other/moderna-and-other-vaccine-maker-stocks-tumble-after-trump-taps-rfk-jr-as-hhs-head/ar-AA1u6mF6


Comments 1 - 9 of 9        Search these comments

1   Patrick   2024 Nov 14, 6:32pm  

We need the death penalty for corporations.

Corporations which repeatedly prove criminal should be completely disbanded and share price set to zero.
2   ElYorsh   2024 Nov 14, 6:37pm  

Or at least long jail sentences for C level executives. You really can't blame them for trying since the money is good and the penalties virtually don't exist.
3   stereotomy   2024 Nov 15, 10:47am  

The last time C-suite execs went to jail was the S&L Crisis in the early 1990's. It's high time psycho execs and anyone who collaborated at the very least get prison time. For the mass murderers - death by hanging, just like Nuremburg.
4   zzyzzx   2024 Nov 15, 11:36am  

Pfizer really getting hit hard here!
5   Misc   2024 Nov 15, 11:44am  

All the executives at Pfizer that made the coin have left the building. Now Pfizer is literally run by a bunch of women. All the males are long gone.
6   Patrick   2024 Nov 15, 12:00pm  

ElYorsh says

You really can't blame them for trying since the money is good and the penalties virtually don't exist.


I know they are obligated to act in the best interest of shareholders, but that should be subject to at least basic morality.
7   Patrick   2024 Nov 19, 7:29pm  




Damn, sure looks like they were in on the whole Plandemic.
9   Al_Sharpton_for_President   2024 Dec 17, 7:42am  

Palantir, MicroStrategy, Axon Make NASDAQ 100 Leap as Moderna, Super Micro Exit

The removal of Moderna, a key player during the COVID-19 pandemic, suggests a recalibration in the market’s focus from pandemic-driven healthcare solutions to other growth areas.

https://thesiliconreview.com/2024/12/palantir-microstrategy-axon-nasdaq


Please register to comment:

api   best comments   contact   latest images   memes   one year ago   random   suggestions   gaiste